U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737600) titled 'A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer' on July 27.
Brief Summary: This is a Phase Ib/II clinical study to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MRG007 combination therapy in patients with advanced colorectal cancer.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Advanced Colorectal Cancer
Intervention:
DRUG: MRG007
MRG007 will be administrated as specified in the protocol.
DRUG: 5-Fluorouracil/Leucovorin Calcium
5-Fluorouracil/Leucovorin Calcium will be administrated as specified in the protocol.
DRUG: Bevacizumab
Bevacizumab will be ad...